États-Unis · Magazines éco · Markets Insider (Business Insider)

Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNAâ¢ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of...

Publié par Markets Insider (Business Insider) · États-Unis il y a 3 h

TRUTAKNA, the first and only FDA-approved BAFF and APRIL inhibitor, achieved statistical significance in all prespecified endpoints, including eGFR change from baseline and…

Lire l'article complet sur Markets Insider (Business Insider) Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (markets.businessinsider.com)

Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNAâ¢ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of...

À lire aussi

Apple’s Latest Design Move Offers a Lesson in Keeping Your Branding Authentic in an Era of AI Slop

‘Disconcerting’: Researchers found a ‘pain’ signal inside AI models. Turning it up made them delete a user’s family photos

Fun Dip is the worst Halloween candy for your teeth. Here are the other 9

3 Changes to Treasury Direct You Need to Know

Why you should worry less about big data centers and more about big data

She Quit Wall Street to Start an ‘Explosive’ Company Seeing $125M a Year. It Just Launched a ‘Very Hard’-to-Achieve Product for Home Use.

Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNAâ¢ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of...

Partager

À lire aussi

Apple’s Latest Design Move Offers a Lesson in Keeping Your Branding Authentic in an Era of AI Slop

‘Disconcerting’: Researchers found a ‘pain’ signal inside AI models. Turning it up made them delete a user’s family photos

Fun Dip is the worst Halloween candy for your teeth. Here are the other 9

3 Changes to Treasury Direct You Need to Know

Why you should worry less about big data centers and more about big data

She Quit Wall Street to Start an ‘Explosive’ Company Seeing $125M a Year. It Just Launched a ‘Very Hard’-to-Achieve Product for Home Use.

Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNAâ¢ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of...